 |
PDBsum entry 4d0f
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
4d0f
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription
|
 |
|
Title:
|
 |
Human notch1 egf domains 11-13 mutant t466a
|
|
Structure:
|
 |
Neurogenic locus notch homolog protein 1. Chain: a. Fragment: egf 11-13. Synonym: notch 1, hn1, translocation-associated notch protein tan-1, human notch. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.225
|
R-free:
|
0.265
|
|
|
Authors:
|
 |
P.Taylor,H.Takeuchi,D.Sheppard,C.Chillakuri,S.M.Lea,R.S.Haltiwanger, P.A.Handford
|
|
Key ref:
|
 |
P.Taylor
et al.
(2014).
Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands.
Proc Natl Acad Sci U S A,
111,
7290-7295.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
25-Apr-14
|
Release date:
|
21-May-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P46531
(NOTC1_HUMAN) -
Neurogenic locus notch homolog protein 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2555 a.a.
125 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 9 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
111:7290-7295
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands.
|
|
P.Taylor,
H.Takeuchi,
D.Sheppard,
C.Chillakuri,
S.M.Lea,
R.S.Haltiwanger,
P.A.Handford.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Notch signaling pathway is essential for many aspects of development, cell
fate determination, and tissue homeostasis. Notch signaling can be modulated by
posttranslational modifications to the Notch receptor, which are known to alter
both ligand binding and receptor activation. We have modified the ligand-binding
region (EGF domains 11-13) of human Notch1 (hN1) with O-fucose and O-glucose
glycans and shown by flow cytometry and surface plasmon resonance that the
Fringe-catalyzed addition of GlcNAc to the O-fucose at T466 in EGF12
substantially increases binding to Jagged1 and Delta-like 1 (DLL1) ligands. We
have subsequently determined the crystal structures of EGF domains 11-13 of hN1
modified with either the O-fucose monosaccharide or the GlcNAc-fucose
disaccharide at T466 of EGF12 and observed no change in backbone structure for
each variant. Collectively, these data demonstrate a role for GlcNAc in
modulating the ligand-binding site in hN1 EGF12, resulting in an increased
affinity of this region for ligands Jagged1 and DLL1. We propose that this
finding explains the Fringe-catalyzed enhancement of Notch-Delta signaling
observed in flies and humans, but suggest that the inhibitory effect of Fringe
on Jagged/Serrate mediated signaling involves other regions of Notch.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |